Nedfrysning af oocytter som fertilitetsbevaring på benign medicinsk og social indikation

Kirsten Tryde Macklon; Nathalie Bülow; Heidi Christensen; Dorthe Hartwell; Kirstine Kirkegaard; Stine Gry Kristensen; Susanne Lund Kristensen; Elisabeth Clare Larsen; Kathrine Birch Petersen; Kåre Rygaard; Abelone Sakse; Lotte Berdiin Colmorn

doi:10.61409/V07240478

Nedfrysning af oocytter som fertilitetsbevaring på benign medicinsk og social indikation

Kirsten Tryde Macklon, Nathalie Bülow, Heidi Christensen, Dorthe Hartwell, Kirstine Kirkegaard, Stine Gry Kristensen, Susanne Lund Kristensen, Elisabeth Clare Larsen, Kathrine Birch Petersen, Kåre Rygaard, Abelone Sakse, Lotte Berdiin Colmorn

Institut for Klinisk Medicin - Kvindesygdomme og Fødsler, Horsens

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Review › Forskning › peer review

Abstract

Cryopreservation of oocytes as a way of preserving fertility for future use can be considered for certain benign diseases and conditions. Benign ovarian cysts, BRCA 1/2 mutation carriers, genetic conditions such as Turner syndrome and Fragile X mutation carriers, and even a low ovarian reserve of unknown origin are examples of such conditions. However, the evidence of the advantage of the procedure is sparse in terms of live births. In general, the recommendation is to freeze oocytes before the age of 38 and preferably >15-20 oocytes.

Bidragets oversatte titel	Freezing of oocytes as fertility preservation for benign medical and social indication
Originalsprog	Dansk
Tidsskrift	Ugeskrift for laeger
Vol/bind	187
Nummer	2
ISSN	0041-5782
DOI	https://doi.org/10.61409/V07240478
Status	Udgivet - 6 jan. 2025

Adgang til dokumentet

10.61409/V07240478

OpenUrl tilgængelighed

Fuld tekst

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{1c63f2071f5d409c8bb1c11455bc277d,

title = "Nedfrysning af oocytter som fertilitetsbevaring p{\aa} benign medicinsk og social indikation",

abstract = "Cryopreservation of oocytes as a way of preserving fertility for future use can be considered for certain benign diseases and conditions. Benign ovarian cysts, BRCA 1/2 mutation carriers, genetic conditions such as Turner syndrome and Fragile X mutation carriers, and even a low ovarian reserve of unknown origin are examples of such conditions. However, the evidence of the advantage of the procedure is sparse in terms of live births. In general, the recommendation is to freeze oocytes before the age of 38 and preferably >15-20 oocytes.",

author = "Macklon, {Kirsten Tryde} and Nathalie B{\"u}low and Heidi Christensen and Dorthe Hartwell and Kirstine Kirkegaard and Kristensen, {Stine Gry} and Kristensen, {Susanne Lund} and Larsen, {Elisabeth Clare} and Petersen, {Kathrine Birch} and K{\aa}re Rygaard and Abelone Sakse and Colmorn, {Lotte Berdiin}",

note = "Publisher Copyright: Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",

year = "2025",

month = jan,

day = "6",

doi = "10.61409/V07240478",

language = "Dansk",

volume = "187",

journal = "Ugeskrift for laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "2",

}

TY - JOUR

T1 - Nedfrysning af oocytter som fertilitetsbevaring på benign medicinsk og social indikation

AU - Macklon, Kirsten Tryde

AU - Bülow, Nathalie

AU - Christensen, Heidi

AU - Hartwell, Dorthe

AU - Kirkegaard, Kirstine

AU - Kristensen, Stine Gry

AU - Kristensen, Susanne Lund

AU - Larsen, Elisabeth Clare

AU - Petersen, Kathrine Birch

AU - Rygaard, Kåre

AU - Sakse, Abelone

AU - Colmorn, Lotte Berdiin

N1 - Publisher Copyright: Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2025/1/6

Y1 - 2025/1/6

N2 - Cryopreservation of oocytes as a way of preserving fertility for future use can be considered for certain benign diseases and conditions. Benign ovarian cysts, BRCA 1/2 mutation carriers, genetic conditions such as Turner syndrome and Fragile X mutation carriers, and even a low ovarian reserve of unknown origin are examples of such conditions. However, the evidence of the advantage of the procedure is sparse in terms of live births. In general, the recommendation is to freeze oocytes before the age of 38 and preferably >15-20 oocytes.

AB - Cryopreservation of oocytes as a way of preserving fertility for future use can be considered for certain benign diseases and conditions. Benign ovarian cysts, BRCA 1/2 mutation carriers, genetic conditions such as Turner syndrome and Fragile X mutation carriers, and even a low ovarian reserve of unknown origin are examples of such conditions. However, the evidence of the advantage of the procedure is sparse in terms of live births. In general, the recommendation is to freeze oocytes before the age of 38 and preferably >15-20 oocytes.

UR - http://www.scopus.com/inward/record.url?scp=85218290911&partnerID=8YFLogxK

U2 - 10.61409/V07240478

DO - 10.61409/V07240478

M3 - Review

C2 - 39917891

AN - SCOPUS:85218290911

SN - 0041-5782

VL - 187

JO - Ugeskrift for laeger

JF - Ugeskrift for laeger

IS - 2

ER -

Nedfrysning af oocytter som fertilitetsbevaring på benign medicinsk og social indikation

Abstract

Adgang til dokumentet

OpenUrl tilgængelighed

Andre filer og links

Fingeraftryk

Citationsformater